New: 100+ health biomarkers for $190
Retatrutide's phase 3 results: 30% weight loss in 2 years

Retatrutide's phase 3 results: 30% weight loss in 2 years

Lilly's triple-agonist hit bariatric-surgery numbers in TRIUMPH-1, with notable cardiometabolic gains and one safety signal worth watching.

• Brandon Ballinger